re: Ann: Breakthrough in Extensively Drug-Res... Got to feel sorry for these guys, great annc but they got money problems.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling